The Role of Pharmacists in Public Health and Disease Prevention: What Do We Know?
Clinical Pharmacy Connect · 2025
DOI: 10.69709/cpc.2025.113833 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Pharmacy Connect, 2025. Verfasst von Ahmad Z. Al Meslamani. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 65 Literaturangaben.
Abstract (Originalsprache)
Background
Non-communicable diseases and persistent infectious threats continue to cause substantial premature mortality. Over 85% of the global population lives within walking distance of a pharmacy, positioning pharmacists as highly accessible primary-health providers.
Aims
To review evidence on pharmacists’ public-health activities, propose a four-domain service framework, and identify barriers limiting scale-up, particularly in low- and middle-income settings.
Methods
A conventional narrative review was conducted. Targeted manual searches of PubMed, Scopus, Web of Science, Google Scholar, professional-association websites, and reference lists retrieved English-language publications from January 2015 to April 2025. Extracted data on context, interventions, and outcomes were narratively synthesised across preventive, diagnostic, therapeutic, and digital domains.
Results
According to 97 studies, pharmacist-led preventive programmes increased vaccination coverage by 51% and achieved verified quit rates of 20–43% in smoking cessation trials. Pharmacy point-of-care testing reduced inappropriate antibiotic use by up to 65% and accelerated triage for malaria, influenza, and streptococcal infections. Chronic-disease services consistently lowered systolic blood pressure by ≈6 mmHg, reduced HbA1c by 0.6–1.0% and cut 30-day readmissions (hazard ratio 0.62). The major barriers include restrictive scope-of-practice regulations, limited reimbursement pathways, insufficient public health training, and underdeveloped digital infrastructure.
Conclusions
Robust evidence demonstrates that pharmacists improve immunization uptake, medication safety, and chronic disease outcomes; however, fragmented policy and financing structures continue to limit their reach. Harmonised legislation, sustainable payment models, and competency-based education are essential to convert pharmacists’ unparalleled accessibility into equitable population-health gains.
Zitieren
APA
Meslamani, A. Z. A. (2025). The Role of Pharmacists in Public Health and Disease Prevention: What Do We Know?. Clinical Pharmacy Connect. https://doi.org/10.69709/cpc.2025.113833
Vancouver
Meslamani AZA. The Role of Pharmacists in Public Health and Disease Prevention: What Do We Know?. Clinical Pharmacy Connect. 2025. doi:10.69709/cpc.2025.113833
BibTeX
@article{Meslamani2025,
author = {Meslamani, Ahmad Z. Al},
title = {The Role of Pharmacists in Public Health and Disease Prevention: What Do We Know?},
journal = {Clinical Pharmacy Connect},
year = {2025},
doi = {10.69709/cpc.2025.113833}
}
EUVIMED